You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

MKSAP 18 "Quiz Me!" Question

Test your medical knowledge each month with questions from The Medical Knowledge Self-Assessment Program® (MKSAP).

MKSAP 18MKSAP has been trusted by internists since 1967 as the best resource for updating knowledge. MKSAP 18, available in Complete, Digital, and Print packages, consists of 11 comprehensive text chapters with related multiple-choice questions. You'll find 1,200 completely new questions to help you identify learning gaps, stay current, and gain the knowledge you need to provide the best possible patient care. MKSAP 18's original and high-quality questions evolve out of case studies and patient scenarios based on the latest evidence.

For more information on MKSAP 18, or to order your copy, visit mksap18.acponline.org.

MKSAP 18 Q & A

A 27-year-old man is evaluated during a routine health maintenance visit with his internist. He asks about reducing his risk for HIV infection because he has sex with men, has multiple partners, and reports using condoms “sometimes.” Medical history is unremarkable, and he takes no medications.

The physical examination is normal.

Laboratory studies show a normal serum creatinine level. A serum rapid plasma reagin test is negative. Nucleic acid amplification testing for gonorrhea and chlamydia from urine, pharynx, and rectum are all negative. An HIV test is negative.

Which of the following is the most appropriate preventive measure?

A: Reinforce consistent condom use and avoid antiretroviral therapy
B: Tenofovir and emtricitabine single dose before each sexual encounter
C: Tenofovir and emtricitabine single dose after each sexual encounter
D: Tenofovir disoproxil fumarate and emtricitabine daily

Answer and Critique

Back to the November 2021 issue of ACP IMpact